CK2 acts via the inactivation of tumor suppressor genes PTEN and IKZF1 (Ikaros) as well as stimulating proliferation and cellular growth in lymphoid malignancies including B-ALL [4]. The gene discussed is IKZF1; the disease is precursor B-cell acute lymphoblastic leukemia.